Chemical Name: | 6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole;hydrochloride |
CAS Number: | 145858-50-0 |
Product Number: | AG001DHF(AGN-PC-0JLA9J) |
Synonyms: | |
MDL No: | MFCD00879803 |
Molecular Formula: | C17H14Cl2N4 |
Molecular Weight: | 345.2259 |
Liarozole hydrochloride is a potent pharmaceutical compound widely utilized in chemical synthesis for its unique properties. This versatile compound is particularly valued for its ability to act as an inhibitor of cytochrome P-450, an essential enzyme involved in the metabolism of various drugs in the body. In the realm of chemical synthesis, Liarozole hydrochloride finds extensive application in the development of novel drug candidates and in the study of drug-drug interactions.Additionally, Liarozole hydrochloride has been employed in the synthesis of pharmaceutical agents targeting skin disorders and cancers, owing to its potential to modulate retinoic acid levels in the body. This makes it a valuable reagent in the production of medications designed to treat conditions such as psoriasis, acne, and certain types of tumors. The precise control exerted by Liarozole hydrochloride on crucial metabolic pathways makes it a key component in the synthesis of compounds with targeted therapeutic effects.Moreover, its role as a cytochrome P-450 inhibitor adds a layer of complexity to chemical synthesis processes, allowing researchers to fine-tune the pharmacokinetic profiles of new drug candidates. By incorporating Liarozole hydrochloride into synthetic routes, chemists can enhance the bioavailability and efficacy of potential medications, thereby broadening the scope of drug discovery and development efforts.